US Device Guide

The Cardiac Interventions Today Europe Device Guide offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.

 

Featured Center

 

CTOs

Current Supplement

 

News

 

LivaNova Agrees to Acquire TandemLife

February 14, 2018 -- LivaNova PLC announced it has entered into an agreement to acquire TandemLife. TandemLife offers four product systems built around a common pump and contr…

Edwards' Self-Expanding Centera Valve Receives CE Mark

February 15, 2018 -- Edwards Lifesciences announced that its self-expanding Centera valve has received CE Mark approval. The Centera valve is indicated for the treatment of se…

Abiomed's Impella 2.5 and CP Heart Pumps Receive Expanded Indication for High-Risk PCI

February 14, 2018 -- Abiomed, Inc. announced its Impella 2.5 and Impella CP heart pump devices have received expanded US Food and Drug Administration (FDA) premarket approval …

Abiomed's Impella Devices Receive Expanded Indication for Cardiomyopathy With Cardiogenic Shock

February 13, 2018 -- Abiomed, Inc. announced that it has received an expanded US Food and Drug Administration (FDA) premarket approval for its Impella 2.5, Impella CP, Impella…

Simplified Angiographic Approach Compared With SYNTAX Score for Left Main Coronary Artery Stenting

February 12, 2018 -- Pil Hyung Lee et al published a study online in Circulation: Cardiovascular Interventions comparing the prognostic value of Synergy Between Percutane…

Lepu Medical's NeoVas Bioresorbable Scaffold Shown to Be Noninferior to Metallic Drug-Eluting Stents

February 12, 2018 -- Findings from a randomized controlled trial show that the NeoVas bioresorbable scaffold (BRS; Lepu Medical Technology (Beijing) Co., Ltd.) is noninferior …

Meta-Analysis Suggests Ulnar Artery May Be a Safe Alternative to Radial Artery for Cardiac Catheterization

February 12, 2018 -- Ritin Fernandez, PhD, et al published meta-analysis data online in Catheterization and Cardiovascular Interventions reviewing six randomized controlled tr…

Bivalirudin and Unfractionated Heparin Compared for Patients With End-Stage Renal Disease Undergoing PCI

February 12, 2018 -- Jeffrey B. Washam, PharmD, et al published a study online in Circulation: Cardiovascular Interventions analyzing anticoagulant use in patients with end-st…

Abbott Vascular's XIENCE 28 GLOBAL Trial Enrolls First Patient in Europe

February 12, 2018 -- Abbott Vascular announced the first patient has been enrolled in XIENCE 28 GLOBAL, a clinical trial evaluating whether patients at high risk of bleeding c…

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.